Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Current Atherosclerosis Reports|January 5, 2008
The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysisAllan D Sniderman, Robert S Kiss
Clinics in Laboratory Medicine|November 18, 2006
Apolipoprotein A1 and BAllan D Sniderman, Santica M Marcovina
JAMA|November 22, 2012
Cardiovascular disease risk prediction factorsAllan D Sniderman, Curt D Furberg
Journal of Clinical Lipidology|October 16, 2018
A failure of standardization or a failure of the process of standardizationAllan D Sniderman, Matthew J McQueen
JAMA|January 30, 2009
Why guideline-making requires reformAllan D Sniderman, Curt D Furberg
JACC. Advances|June 28, 2024
Coronary Atherosclerosis: Causes, Consequences, and the Passage of TimePeter P Toth, Allan D Sniderman
Current Cardiology Reports|June 21, 2020
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?Michel R Langlois, Allan D Sniderman
JAMA|August 29, 2017
Genetic Studies Help Clarify the Complexities of Lipid Biology and TreatmentAllan D Sniderman, Eric D Peterson
Atherosclerosis|November 23, 2018
ApoB in clinical care: Pro and ConAllan D Sniderman, Jennifer G Robinson
Current Opinion in Lipidology|April 19, 2015
Limitations in the conventional assessment of the incremental value of predictors of cardiovascular riskAllan D Sniderman, Michael Pencina, George Thanassoulis
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Current Atherosclerosis Reports|January 5, 2008
The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysisAllan D Sniderman, Robert S Kiss
Clinics in Laboratory Medicine|November 18, 2006
Apolipoprotein A1 and BAllan D Sniderman, Santica M Marcovina
JAMA|November 22, 2012
Cardiovascular disease risk prediction factorsAllan D Sniderman, Curt D Furberg
Journal of Clinical Lipidology|October 16, 2018
A failure of standardization or a failure of the process of standardizationAllan D Sniderman, Matthew J McQueen
JAMA|January 30, 2009
Why guideline-making requires reformAllan D Sniderman, Curt D Furberg
JACC. Advances|June 28, 2024
Coronary Atherosclerosis: Causes, Consequences, and the Passage of TimePeter P Toth, Allan D Sniderman
Current Cardiology Reports|June 21, 2020
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?Michel R Langlois, Allan D Sniderman
JAMA|August 29, 2017
Genetic Studies Help Clarify the Complexities of Lipid Biology and TreatmentAllan D Sniderman, Eric D Peterson
Atherosclerosis|November 23, 2018
ApoB in clinical care: Pro and ConAllan D Sniderman, Jennifer G Robinson
Current Opinion in Lipidology|April 19, 2015
Limitations in the conventional assessment of the incremental value of predictors of cardiovascular riskAllan D Sniderman, Michael Pencina, George Thanassoulis
Pageof 17